Good candidates People who may benefit from Belmar compounded semaglutide include those with a BMI of 30 or above (obesity), those with a BMI of 27 or above with at least one weight-related health condition (hypertension, type 2 diabetes, high cholesterol), people who have tried diet and exercise without achieving adequate weight loss, and patients who cannot access or afford brand-name semaglutide products
Precautions and contraindications Do not use this medication if you are allergic to any of the components
The GLP-1 receptor agonist works through multiple pathways in the body: Stimulating insulin production when blood sugar levels rise Reducing glucagon release from the pancreas Slowing the movement of food through the digestive system Sending signals to the brain that create feelings of fullness Regulating appetite centers in the hypothalamus Related medications containing semaglutide have expanded the drugs market reach
Standard deductibles, coinsurance, and copays may apply
This medication is also prescribed for patients with a BMI over 27 kg/m who have experienced heart attacks and strokes, to lower their risk of future cardiovascular events